Navigation Links
Drugs With Marijuana Compounds Don't Boost Adverse Events
Date:6/28/2008

But Canadian study finds increase in non-serious side effects

FRIDAY June 27 (HealthDay News) -- Drugs that contain compounds called cannabinoids from the marijuana plant don't increase the risk of serious side effects but are associated with an increase in some non-serious side effects, Canadian scientists report.

The researchers at McGill University in Montreal and the University of British Columbia (UBC) examined adverse events reported in 31 clinical studies of cannabinoid medications conducted between 1966 and 2007.

The adverse events were grouped as serious or non-serious. Serious adverse events included those that led to hospitalization, disability or death. Non-serious adverse events included dizziness and drowsiness.

"Overall, we found an 86 percent increase in the rate of non-serious adverse events among the patients treated with cannabinoids compared to the patients in the control groups," Dr. Mark Ware, a neurosciences researcher at the Research Institute of the McGill University Health Centre, said in a prepared statement.

Most of the non-serious side effects were mild to moderate in severity.

The study was published in the June 16 issue of the Canadian Medical Association Journal.

Cannabinoids have been shown to help treat chronic pain from diseases such as cancer, multiple sclerosis, arthritis and fibromyalgia. The drugs also stimulate appetite and relieve nausea, according to background information in the study.

Doctors must balance the benefits of these drugs against possible side effects, the researchers said.

"We have summarized the adverse events from these studies to help educate physicians and patients about the possible risks of medical cannabinoids. We cannot extend these results to smoked cannabis or recreational use. That will require further research," Dr. Jean-Paul Collet, senior researcher at the Child & Family Research Institute and director of the Centre for Applied Health Research and Evaluation at British Columbia Children's Hospital, said in a prepared statement.

More information

The National Pain Foundation has more about cannabinoids.



-- Robert Preidt



SOURCE: McGill University, news release, June 16, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. ADHD Gene Doesnt Predict Response to Drugs
2. Failure to Take Seizure Drugs Boosts Death Risk
3. Computers as safe as medical experts in prescribing blood thinning drugs
4. Drink and drugs fuel Scottish suicide and homicide rates
5. New Class of Drugs May Fight Alzheimers
6. Targeted Anticancer Drugs - In Vitro Assessment and Non-Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success
7. FDA Starts Safety Review of Autoimmune Disorder Drugs
8. Synthetic molecules hold promise for new family of anti-cancer drugs
9. Isis Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
10. Anemia Drugs May Speed Tumor Growth in Some Cancer Patients
11. China Nepstar Chain Drugstore Filed Its Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching ... innovative Unified Instance Manager architecture, meeting the needs of multichannel growth and ... the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to announce that ... for Texas, they are expanding their presence in Dallas. One of the most exciting ... bring new jobs to the Dallas and Forth Worth market. STAT takes pride in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Healthcare is ... Dr. Botelho advocates for the mass media launching of story movements to highlight ... to share their unfortunate experiences; such a movement can generate the network power ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Valeant Pharmaceuticals International, Inc. (NYSE: ... positive results from a Phase 3, multicenter double-blind, ... and efficacy of IDP-118 (halobetasol propionate and tazarotene) ... Within the Phase 3 study of ... IDP-118 showed statistical significance to vehicle with a ...
(Date:12/8/2016)... Texas , Dec. 8, 2016 ... program that brings leading-edge laboratory services and management ... United States , allowing more doctors and ... health care management solutions. Logo - ... Hospital systems, under pressure to contain ...
(Date:12/8/2016)... Information products and services provider Elsevier has ... the world,s largest abstract and citation database of peer-reviewed literature, providing ... over 5,000 publishers. The new set of metrics will improve decisions ... to adjust a journal,s editorial strategy. ... , , CiteScore metrics ...
Breaking Medicine Technology: